To investigate the treatment of secondary hyperparathyroidism (SHPT) with ultrasound-guided percutaneous radiofrequency ablation (RFA).
Methods:
A total of 36 SHPT patients were selected as the study subjects
of which 16 were treated with ultrasound guided RFA
20 underwent traditional parathyroidectomy (PTX). The clinical data
lab
oratory examination (postoperative 1 d
1 week
1 month
3 months
6 months and 1 year of parathyroid hormone (PTH)
calcium (Ca)
blood phosphorus (P) and alkaline phosphatase (ALP) levels were analyzed. The improvement of clinical symptoms and complications were observed
and the safety and efficacy of treatment were evaluated.
Results:
After 1 d
1 week
1 month
3 months
6 months and 1 year
the levels of PTH
Ca and P in 2 groups were significantly decreased (
P
<0.05)
and the ALP levels were no significant difference before and after operation (
P
>0.05). There was no significant difference in postoperative laboratory indexes between 2 groups (
P
>0.05). Postoperative muscle weakness
bone pain
skin pruritus and neurological symptoms were significantly improved in both groups. There was 1 case of hoarseness combined with hypocalcemia and 1 case of postoperative intermuscular hematoma after RFA;1 case of hypocalcemia and 1 case of hoarseness after PTX. There were no significant differences between 2 groups (
P
>0.05).
Conclusion:
The efficacy of ultrasound-guided RFA in the treatment of SHPT is similar to PTX
which can significantly improve the patients clinical symptoms and quality of life.